BIOMARIN PHARMACEUTICAL INC Accounts Payable
BIOMARIN PHARMACEUTICAL INC (BMRN) had Accounts Payable of $26.14 million as of 2015-06-30, per its 10-Q filed 2015-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2015-08-05
- 2015-06-30: Accounts Payable, Current $26.14M.
- 2015-03-31: Accounts Payable, Current $23.61M.
- 2014-12-31: Accounts Payable, Current $32.78M.
- 2014-09-30: Accounts Payable, Current $37.69M.
| Period end | Accounts Payable, Current |
|---|---|
| 2015-06-30 | $26.14M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $23.61M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $32.78M 10-Q · filed 2015-08-05 |
| 2014-09-30 | $37.69M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $21.71M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $15.33M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $36.89M 10-K · filed 2015-03-02 |
| 2013-09-30 | $15.63M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $16.26M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $25.47M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $23.99M 10-K · filed 2014-02-26 |
| 2012-09-30 | $11.46M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $12.50M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $12.44M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $12.24M 10-K · filed 2013-02-26 |
| 2011-09-30 | $7.11M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $7.25M 10-Q · filed 2011-08-01 |
| 2010-12-31 | $4.96M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |